WST

$237.03-3.30 (-1.37%)

Market ClosedAs of Mar 20, 8:00 PM UTC

West Pharmaceutical Services, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$237.03
Potential Downside
39.7%
Whystock Fair Value$142.86
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Pro...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$17.09B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
34.96
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
15.36%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.34

Recent News

StockStory
Mar 20, 2026

1 Cash-Heavy Stock to Keep an Eye On and 2 That Underwhelm

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 20, 2026

Here's Why You Should Add McKesson Stock to Your Portfolio Now

McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 19, 2026

ALGN or WST: Which Is the Better Value Stock Right Now?

ALGN vs. WST: Which Stock Is the Better Value Option?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 19, 2026

3 High-Flying Stocks We Keep Off Our Radar

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 16, 2026

The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services

Dividend Aristocrats like Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services offer steady income as geopolitical tensions and oil price spikes rattle markets.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.